Retinyl palmitate-loaded poly(lactide-co-glycolide) nanoparticles for the topical treatment of skin diseases

Journal of Bioactive and Compatible Polymers

Volumn 27, Issue 6, 2012, Pages 604-620

  Errico, Cesare ^a   Goñi De Cerio, Felipe ^b   Alderighi, Michele ^a   Ferri, Marcella ^a   Suarez Merino, Blanca ^b   Soroka, Yoram ^c   Frǔié Zlotkin, Marina ^c   Chiellini, Federica ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Centro Tecnologico Gaiker   (Spain)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

cytokine production cytotoxicity; genotoxicity; glass transition temperature; oxygen species; polymeric nanoparticles; Retinyl palmitate

Indexed keywords

CYTOKINE PRODUCTION; GENOTOXICITIES; OXYGEN SPECIES; POLYMERIC NANOPARTICLES; RETINYL PALMITATE;

ATOMIC FORCE MICROSCOPY; BROMINE COMPOUNDS; CELL CULTURE; CELL MEMBRANES; DIFFERENTIAL SCANNING CALORIMETRY; ELASTICITY; GLASS TRANSITION; OXYGEN; PHOSPHOLIPIDS; SKIN; ZETA POTENTIAL;

NANOPARTICLES;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOKINE; NANOCARRIER; PHOSPHOLIPID; POLOXAMER; POLYGLACTIN; REACTIVE OXYGEN METABOLITE; RETINOL PALMITATE;

AMES TEST; ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; ELASTICITY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LIGHT SCATTERING; MOUSE; NONHUMAN; SKIN DISEASE; SKIN FIBROBLAST; TOPICAL TREATMENT; ZETA POTENTIAL;

EID: 84869066056     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911512461107     Document Type: Article

References (36)

1. Baumann L. Skin ageing and its treatment. J Pathol. 2007 ; 211: 241-251
2. Chiu A, Kimball AB. Topical vitamins, minerals and botanical ingredients as modulators of environmental and chronological skin damage. Br J Dermatol. 2003 ; 149: 681-691
3. Griffiths CE. The role of retinoids in the prevention and repair of aged and photoaged skin. Clin Exp Dermatol. 2001 ; 26: 613-618
4. Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?. J Pharm Sci. 2010 ; 99 (1). 21-50
5. Küchler S, Radowski MR, Blaschke T, et al. Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell- nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm. 2009 ; 71: 243-250
6. Sachs DL, Voorhees JJ. Age-reversing drugs and devices in dermatology. Clin Pharmacol Ther. 2011 ; 89 (1). 34-43
7. Singh M, Griffiths CE. The use of retinoids in the treatment of photoaging. Dermatol Ther. 2006 ; 19: 297-305
8. Arayachukeat S, Wanichwecharungruang SP, Tree-Udom T. Retinyl acetate-loaded nanoparticles: dermal penetration and release of the retinyl acetate. Int J Pharm. 2010 ; 404: 281-288
9. Saurat JH. Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol. 1999 ; 41 (3 Pt 2). S2 - S6
10. Bos JD, Spuls PI. Topical treatments in psoriasis: today and tomorrow. Clin Dermatol. 2008 ; 26: 432-437
11. Van De Kerkhof PC. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther. 2006 ; 19: 252-263
12. Kligman AM, Grove GL, Hirose R, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986 ; 15 (4 Pt 2). 836-859
13. Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007 ; 59: 427-443
14. Schneider M, Stracke F, Hansen S, et al. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009 ; 1: 197-206
15. Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights. 2007 ; 2: 147-157
16. De O Monteiro E, Baumann LS. The science of cosmeceuticals. Expet Rev Dermatol. 2006 ; 1: 379-389
17. Dong Y, Feng SS. In vitro and in vivo evaluation of methoxy poly(ethylene glycol)-poly(lactide acid) (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy. Biomaterials. 2007 ; 28: 4154-4160
18. Teixeira Z, Zanchetta B, Melo BA, et al. Retinyl palmitate flexible polymeric nanocapsules: characterization and permeation studies. Colloids Surf B Biointerfaces. 2010 ; 8: 374-380
19. Carelli AA, Brevedan MIV, Crapiste GH. Quantitative determination of phospholipids in sunflower oil. J Am Oil Chem Soc. 1997 ; 74 (5). 511-514
20. Kim J, Shim J, Kim YJ, et al. The design of polymer-based nanocarriers for effective transdermal delivery. Macromol Biosci. 2010 ; 10: 1171-1176
21. Chen Y, Wan Y, Wang Y, et al. Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Int J Nanomedicine. 2011 ; 6: 2321-2326
22. Tang H, Guo J, Sun Y, et al. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm. 2011 ; 421: 388-396
23. Yang Y, Qu Y, Lü X. Global gene expression analysis of the effects of gold nanoparticles on human dermal fibroblasts. J Biomed Nanotechnol. 2010 ; 6: 234-246
24. Tian F, Cui D, Schwarz H, et al. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro. 2006 ; 20: 1202-1212
25. Zhang LW, Zeng L, Barron AR, et al. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int J Toxicol. 2007 ; 26: 103-113
26. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol. 2009 ; 234: 222-235
27. Dinarello CA. Proinflammatory cytokines. Chest. 2000 ; 118: 503-508
28. Schanen BC, Karakoti AS, Seal S, et al. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano. 2009 ; 3: 2523-2532
29. Roncarolo MG, Battaglia M, Gregori S. The role of interleukin 10 in the control of autoimmunity. J Autoimmun. 2003 ; 20: 269-272
30. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2004 ; 20: 281-285
31. Matsuzawa A, Saegusa K, Noguchi T, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol. 2005 ; 6: 587-592
32. Tomoda K, Watanabe A, Suzuki K, et al. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf B Biointerfaces. 2012 ; 97: 84-89
33. Kubowicz S, Schmid R, Milner Y, Soroka Y, Zlotkin M, Oron M Proceedings of the 37th Annual Meeting of the Controlled Released Society (Portland, Oregon, USA). St. Paul, MN, USA: ; 2010: 79-80.
34. Tomoda K, Terashima H, Suzuki K, et al. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf B Biointerfaces. 2011 ; 88: 706-710
35. Desai MP, Labhasetwar V, Walter E, et al. The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent. Pharm Res. 1997 ; 14 (11). 1568-1573
36. Zhang W, Gao J, Zhu Q, et al. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm. 2010 ; 402: 205-212